218 related articles for article (PubMed ID: 34264123)
1. Celecoxib repurposing in cancer therapy: molecular mechanisms and nanomedicine-based delivery technologies.
Khafaga AF; Shamma RN; Abdeen A; Barakat AM; Noreldin AE; Elzoghby AO; Sallam MA
Nanomedicine (Lond); 2021 Aug; 16(19):1691-1712. PubMed ID: 34264123
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in herbal combination nanomedicine for cancer: delivery technology and therapeutic outcomes.
Anwar DM; El-Sayed M; Reda A; Fang JY; Khattab SN; Elzoghby AO
Expert Opin Drug Deliv; 2021 Nov; 18(11):1609-1625. PubMed ID: 34254868
[No Abstract] [Full Text] [Related]
3. Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets.
Mottini C; Napolitano F; Li Z; Gao X; Cardone L
Semin Cancer Biol; 2021 Jan; 68():59-74. PubMed ID: 31562957
[TBL] [Abstract][Full Text] [Related]
4. Drug Repurposing in Anticancer Reagent Development.
Chen PC; Liu X; Lin Y
Comb Chem High Throughput Screen; 2017; 20(5):395-402. PubMed ID: 28025934
[TBL] [Abstract][Full Text] [Related]
5. Drug repurposing for cancer therapy, easier said than done.
Gonzalez-Fierro A; Dueñas-González A
Semin Cancer Biol; 2021 Jan; 68():123-131. PubMed ID: 31877340
[TBL] [Abstract][Full Text] [Related]
6. Nanomedicine-based combination anticancer therapy between nucleic acids and small-molecular drugs.
Huang W; Chen L; Kang L; Jin M; Sun P; Xin X; Gao Z; Bae YH
Adv Drug Deliv Rev; 2017 Jun; 115():82-97. PubMed ID: 28624478
[TBL] [Abstract][Full Text] [Related]
7. Developing New Cancer Nanomedicines by Repurposing Old Drugs.
Yang B; Shi J
Angew Chem Int Ed Engl; 2020 Dec; 59(49):21829-21838. PubMed ID: 32270570
[TBL] [Abstract][Full Text] [Related]
8. Repurposing old drugs to fight multidrug resistant cancers.
Dinić J; Efferth T; García-Sosa AT; Grahovac J; Padrón JM; Pajeva I; Rizzolio F; Saponara S; Spengler G; Tsakovska I
Drug Resist Updat; 2020 Sep; 52():100713. PubMed ID: 32615525
[TBL] [Abstract][Full Text] [Related]
9. Repurposing drugs as pro-oxidant redox modifiers to eliminate cancer stem cells and improve the treatment of advanced stage cancers.
Ralph SJ; Nozuhur S; ALHulais RA; Rodríguez-Enríquez S; Moreno-Sánchez R
Med Res Rev; 2019 Nov; 39(6):2397-2426. PubMed ID: 31111530
[TBL] [Abstract][Full Text] [Related]
10. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
11. Drug-repositioning opportunities for cancer therapy: novel molecular targets for known compounds.
Würth R; Thellung S; Bajetto A; Mazzanti M; Florio T; Barbieri F
Drug Discov Today; 2016 Jan; 21(1):190-199. PubMed ID: 26456577
[TBL] [Abstract][Full Text] [Related]
12. Drug Repurposing in the Development of Anticancer Agents.
Olgen S; Kotra LP
Curr Med Chem; 2019; 26(28):5410-5427. PubMed ID: 30009698
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 inhibitors in lung cancer treatment: Bench to bed.
Liu R; Xu KP; Tan GS
Eur J Pharmacol; 2015 Dec; 769():127-33. PubMed ID: 26548623
[TBL] [Abstract][Full Text] [Related]
14. Diethyldithiocarbamate-copper nanocomplex reinforces disulfiram chemotherapeutic efficacy through light-triggered nuclear targeting.
Ren L; Feng W; Shao J; Ma J; Xu M; Zhu BZ; Zheng N; Liu S
Theranostics; 2020; 10(14):6384-6398. PubMed ID: 32483459
[TBL] [Abstract][Full Text] [Related]
15. Repurposing psychiatric drugs as anti-cancer agents.
Huang J; Zhao D; Liu Z; Liu F
Cancer Lett; 2018 Apr; 419():257-265. PubMed ID: 29414306
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs in the anticancer effects of celecoxib: A systematic review.
Mishan MA; Khazeei Tabari MA; Zargari M; Bagheri A
Eur J Pharmacol; 2020 Sep; 882():173325. PubMed ID: 32615181
[TBL] [Abstract][Full Text] [Related]
17. Repurposing of drugs as STAT3 inhibitors for cancer therapy.
Thilakasiri PS; Dmello RS; Nero TL; Parker MW; Ernst M; Chand AL
Semin Cancer Biol; 2021 Jan; 68():31-46. PubMed ID: 31711994
[TBL] [Abstract][Full Text] [Related]
18. Challenges and Opportunities for Celecoxib Repurposing.
Bąk U; Krupa A
Pharm Res; 2023 Oct; 40(10):2329-2345. PubMed ID: 37552383
[TBL] [Abstract][Full Text] [Related]
19. Old wine in new bottles: Drug repurposing in oncology.
Antoszczak M; Markowska A; Markowska J; Huczyński A
Eur J Pharmacol; 2020 Jan; 866():172784. PubMed ID: 31730760
[TBL] [Abstract][Full Text] [Related]
20. Drug repurposing for cancer therapy.
Xia Y; Sun M; Huang H; Jin WL
Signal Transduct Target Ther; 2024 Apr; 9(1):92. PubMed ID: 38637540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
